high investments in research. The National Cancer Institute received USD 5.665 billion from
the States Congress for cancer research programs in 2018.
It is estimated that Europe was the second largest in the Global Microarray Analysis Market.
The rising focus on drug discovery, personalized medicines, and targeted therapy are
driving the growth of the market in this region. In November 2016, over 30 European and
international members along with the European Commission established an initiative called
the International Consortium for Personalized Medicine, or "ICPerMed" to establish Europe
as a global leader in personalized medicine research. Thus, the increasing research in
personalized medicines serves favorable backgrounds for the market to grow in this region.
The Microarray Analysis Market in Asia-Pacific is expected to witness growth owing to rising
prevalence of genetic disorders, growing awareness among the people, and government
initiatives. According to Alzheimer's Disease International, in 2015, 23 million people in the
Asia-Pacific region had dementia, and by 2050 the number is expected to rise to 71 million.
The Middle East and Africa holds the least share in the Global Microarray Analysis Market
due to low funding in medical and health research. However, the rising prevalence of
genetic diseases and increasing healthcare spending favor the market growth in this region.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
…Continued!
Reports Enquiry @ https://www.marketresearchfuture.com/enquiry/896